Squarepoint’s NEVRO CORP. NVRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-82,091
| Closed | -$479K | – | 5230 |
|
|
2025
Q1 | $479K | Buy |
+82,091
| New | +$432K | ﹤0.01% | 3339 |
|
|
2023
Q3 | – | Sell |
-96,737
| Closed | -$2.46M | – | 4345 |
|
|
2023
Q2 | $2.46M | Buy |
96,737
+5,976
| +7% | +$173K | 0.01% | 1527 |
|
|
2023
Q1 | $3.28M | Buy |
90,761
+85,276
| +1,555% | +$2.99M | 0.01% | 1108 |
|
|
2022
Q4 | $217K | Sell |
5,485
-8,506
| -61% | -$354K | ﹤0.01% | 2739 |
|
|
2022
Q3 | $652K | Sell |
13,991
-8,633
| -38% | -$401K | ﹤0.01% | 2061 |
|
|
2022
Q2 | $992K | Buy |
+22,624
| New | +$1.24M | 0.01% | 1607 |
|
|
2022
Q1 | – | Sell |
-46,082
| Closed | -$3.74M | – | 3657 |
|
|
2021
Q4 | $3.74M | Buy |
46,082
+32,043
| +228% | +$3.21M | 0.01% | 921 |
|
|
2021
Q3 | $1.63M | Buy |
14,039
+925
| +7% | +$121K | ﹤0.01% | 1302 |
|
|
2021
Q2 | $2.17M | Buy |
13,114
+1,165
| +10% | +$182K | 0.01% | 1140 |
|
|
2021
Q1 | $1.67M | Sell |
11,949
-20,091
| -63% | -$3.28M | 0.01% | 1170 |
|
|
2020
Q4 | $5.55M | Buy |
32,040
+8,785
| +38% | +$1.42M | 0.04% | 445 |
|
|
2020
Q3 | $3.24M | Buy |
+23,255
| New | +$3.11M | 0.04% | 485 |
|
|
2020
Q1 | – | Sell |
-25,623
| Closed | -$3.01M | – | 2647 |
|
|
2019
Q4 | $3.01M | Buy |
+25,623
| New | +$2.54M | 0.02% | 689 |
|
|
2019
Q3 | – | Sell |
-5,600
| Closed | -$363K | – | 2736 |
|
|
2019
Q2 | $363K | Sell |
5,600
-34,165
| -86% | -$2.13M | ﹤0.01% | 1844 |
|
|
2019
Q1 | $2.49M | Buy |
39,765
+19,396
| +95% | +$912K | 0.03% | 683 |
|
|
2018
Q4 | $792K | Buy |
20,369
+15,171
| +292% | +$674K | 0.01% | 1020 |
|
|
2018
Q3 | $296K | Buy |
+5,198
| New | +$325K | ﹤0.01% | 1545 |
|
|
2018
Q1 | – | Sell |
-15,620
| Closed | -$1.08M | – | 2228 |
|
|
2017
Q4 | $1.08M | Buy |
+15,620
| New | +$1.25M | 0.02% | 793 |
|
|
2017
Q2 | – | Sell |
-7,993
| Closed | -$749K | – | 1863 |
|
|
2017
Q1 | $749K | Sell |
7,993
-9,187
| -53% | -$832K | 0.02% | 709 |
|
|
2016
Q4 | $1.25M | Buy |
+17,180
| New | +$1.47M | 0.05% | 427 |
|
Other funds holding NVRO
Squarepoint's NVRO Position: Q2 2025 in Review
Squarepoint sold out of NEVRO CORP. (NVRO) in Q2 2025, closing a stake of 82,091 shares — an estimated $479K sold.
Squarepoint first reported a position in NVRO in Q4 2016 and held it in 20 quarters. The position peaked at $5.55M in Q4 2020. 1 fund tracked by Wall St. Rank holds NVRO as of Q2 2025.
- Squarepoint reported no remaining NEVRO CORP. position as of Q2 2025 after selling out during the quarter.
- Squarepoint sold 82,091 NEVRO CORP. shares in Q2 2025, an estimated $479K.
- Squarepoint first reported a position in NEVRO CORP. in Q4 2016 and held it in 20 quarters.
- Squarepoint's NEVRO CORP. position peaked at $5.55M in Q4 2020.
- 1 fund tracked by Wall St. Rank held NEVRO CORP. as of Q2 2025.
Based on Squarepoint's 13F filing for Q2 2025, filed 14 Aug 2025.